Matinas BioPharma Holdings, Inc.
MTNB
$0.18
$0.000.93%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 0.00 | -- | -- |
| Gross Profit | -- | -- | 0.00 | -- | -- |
| SG&A Expenses | 1.56M | 1.94M | 1.60M | 1.58M | 1.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.56M | 1.94M | 1.60M | 1.58M | 1.84M |
| Operating Income | -1.56M | -1.94M | -1.60M | -1.58M | -1.84M |
| Income Before Tax | -1.33M | -1.92M | -1.91M | -1.53M | -5.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.33M | -1.92M | -1.91M | -1.53M | -5.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.33M | -1.92M | -1.91M | -1.53M | -5.25M |
| EBIT | -1.56M | -1.94M | -1.60M | -1.58M | -1.84M |
| EBITDA | -1.55M | -1.93M | -1.60M | -1.58M | -1.82M |
| EPS Basic | -0.21 | -0.30 | -0.30 | -0.40 | -1.03 |
| Normalized Basic EPS | -0.15 | -0.19 | -0.18 | -0.18 | -0.23 |
| EPS Diluted | -0.21 | -0.30 | -0.30 | -0.40 | -1.03 |
| Normalized Diluted EPS | -0.15 | -0.19 | -0.18 | -0.18 | -0.23 |
| Average Basic Shares Outstanding | 6.41M | 6.41M | 6.28M | 5.44M | 5.09M |
| Average Diluted Shares Outstanding | 6.41M | 6.41M | 6.28M | 5.44M | 5.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |